Owll Translator App Introduces AI Voice Cloning to Personalize Voice Translations in Over 100 Languages KBRA Releases U.S. Bank 1Q22 Compendium
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its First-Quarter 2022 U.S. Bank Compendium. The Compendium provides our latest…
Sana Biotechnology Congratulates Senior Vice President and Head of T Cell Therapeutics, Terry Fry, M.D., on Additional Role at the University of Colorado’s Gates Institute
SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
Fulcrum Therapeutics to Present Initial Data from Phase 1b Trial of FTX-6058 in Adults Living with Sickle Cell Disease at the European Hematology Association (EHA) Hybrid Congress in Vienna, Austria
– FTX-6058 is the only oral hemoglobin F (HbF) inducer in clinical development -Data will…
Crinetics Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Phase 1 Multiple-Ascending Dose Data for CRN04894 Expected in 2Q22 Paltusotine’s Phase 3 PATHFNDR Trials…
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2022
◦ UCART20x22 preclinical data presented at AACR demonstrated PoC with robust in vitro and in vivo…
Belite Bio Announces Partial Exercise of Over-Allotment Option in Initial Public Offering
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or…
Day One Reports First Quarter 2022 Financial Results and Provides Business Update
Initial data from pivotal FIREFLY-1 study with tovorafenib (DAY101) in relapsed pediatric low-grade glioma (pLGG)…
Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a…
Checkpoint Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
Positive top-line results from registration-enabling study of cosibelimab in metastatic cutaneous squamous cell carcinoma announced…
Editas Medicine Receives FDA Orphan Drug Designation for EDIT-301 for the Treatment of Beta Thalassemia
Company on track to dose first transfusion-dependent beta thalassemia patient with EDIT-301 by year-end CAMBRIDGE, Mass.,…
Molecular Templates, Inc. Reports First Quarter 2022 Financial Results
AUSTIN, Texas, May 12, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
Black Diamond Therapeutics Announces Publication of New Computational and Functional Analyses of HER2 Mutations Based on its Proprietary MAP Discovery Engine
– Peer-reviewed publication highlights 22 new oncogenic HER2 driver mutations identified and experimentally validated with…
DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting
Montrouge, France, May 12, 2022 DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary…
DIVILAND (DVLD) Is Now Available for Trading on LBank Exchange
Internet City, Dubai–(Newsfile Corp. – May 12, 2022) – LBank Exchange, a global digital asset…
LBank Exchange Will List Pieme (PIE) on May 12, 2022
Internet City, Dubai–(Newsfile Corp. – May 12, 2022) – LBank Exchange, a global digital asset…
Astex Announces That the Phase 3 ASCERTAIN – Acute Myeloid Leukemia (AML) Clinical Study of Oral Hypomethylating Agent Decitabine and Cedazuridine Fixed-Dose Combination (ASTX727 or DEC-C) Met the Trial’s Primary Endpoint
The phase 3 ASCERTAIN – AML clinical study of decitabine and cedazuridine, administered orally as…
Teucrium Agricultural Strategy No K-1 ETF (TILL) Declared Effective
BURLINGTON, Vt.–(BUSINESS WIRE)–Teucrium Trading, LLC, the Sponsor of agricultural futures-based ETFs, today announced that its…
United Illuminating Announces New Partnership With Bidgely to Assist in State EV Charging Program
Bidgely will utilize their first-of-its-kind load management technology to assist in the large scale EV…
Zillion Announces the Hiring of Chief Medical Officer, Dr. Cate Collings, M.D., MS, FACC, Dip ABLM
Dr. Collings brings her more than 30 years of experience to the telehealth leader. NORWALK,…
Sonida Senior Living Announces First Quarter 2022 Earnings Release Date and Conference Call
DALLAS–(BUSINESS WIRE)–$SNDA–Sonida Senior Living, Inc. (NYSE: SNDA) (Sonida or the Company) announced today that it…